Isomorphic Labs

Isomorphic Labs secures $2.1B to scale AI drug design engine

Alphabet-backed Isomorphic Labs raised $2.1 billion in Series B funding to advance its IsoDDE AI platform for drug discovery and develop therapeutic pipelines. Led by Thrive Capital with participation from GV, CapitalG, and others, the funds will fuel global expansion and talent acquisition.